首页> 外文OA文献 >Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

【2h】

Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

机译：校正：在体外和体内淋巴瘤细胞中PLK1和HDAC抑制剂之间的协同相互作用，并通过多种机制进行

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tri Nguyen; Rebecca Parker; Elisa Hawkins; Beata Holkova; Victor Yazbeck; Akhil Kolluri; Maciej Kmieciak; Mohamed Rahmani; Steven Grant;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells (Retraction of Vol 13, Pg 2886, 2014) [J] . Dasmahapatra Girija, Patel Hiral, Friedberg Johnathan, Molecular cancer therapeutics . 2019,第6期

机译：在非霍奇金淋巴瘤细胞中的HDAC6抑制剂里吡喹酮（ACY1215）与不可逆蛋白酶体抑制剂Carfilzomib（Vol 13，PG 2886,2014的收缩）之间的体外和体内相互作用
2. IN Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells [J] . Dasmahapatra Girija, Patel Hiral, Friedberg Johnathan, Molecular cancer therapeutics . 2014,第12期

机译：非霍奇金淋巴瘤细胞中HDAC6抑制剂Ricolinostat（ACY1215）与不可逆蛋白酶体抑制剂Carfilzomib之间的体外和体内相互作用
3. PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo [J] . DasmahapatraG., PatelH., NguyenT., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第2期

机译：在体外和体内，PLK1抑制剂在甲磺酸伊马替尼敏感或耐药的BCR / ABL +白血病细胞中协同增强HDAC抑制剂的致死性
4. PHOSPHOLIPIDS' SERA AND MONONUCLEAR CELLS IN ACUTE LEUKEMIA, MALIGNANT LYMPHOMA AND MULTIPLE MYELOMA-EVALUATION BY ~(31)P MRS IN VITRO [C] . M. KULISZKIEWICZ-JANUS, B. BACZYNSKI NATO advanced research workshop on magnetic resonance in colloid and interface science . 2002

机译：磷脂的血清和单核细胞在急性白血病，恶性淋巴瘤和多发性骨髓瘤 - 评估中由〜（31）PRS体外
5. IgE anti-HIV-1 in serum of HIV-1 infected children inhibits HIV-1 production in vitro and IgE mediates cytotoxicity against lymphoma cells expressing HIV-1 and peripheral blood mononuclear cells from an HIV-1 seropositive patient [D] . Bluth, Martin Heath. 1997

机译：HIV-1感染儿童血清中的IgE抗HIV-1抑制了HIV-1的体外产生，IgE介导了对HIV-1血清反应阳性患者表达HIV-1的淋巴瘤细胞和外周血单核细胞的细胞毒性
6. Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms [O] . Tri Nguyen, Rebecca Parker, Elisa Hawkins, 2019

机译：更正：非霍奇金淋巴瘤细胞中PLK1和HDAC抑制剂之间的协同相互作用发生在体外和体内并通过多种机制进行
7. Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms [O] . Tri Nguyen, Rebecca Parker, Elisa Hawkins, 2017

机译：在体外和体内，在非霍奇金淋巴瘤细胞中PLK1和HDAC抑制剂之间的协同相互作用，并通过多种机制进行

Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

著录项

引文网络

相似文献

相关主题

期刊订阅